Cargando…
Apixaban for the prophylaxis and treatment of deep vein thrombosis and pulmonary embolism: an evidence-based review
Venous thromboembolism (VTE) results in significant morbidity and mortality. The prevention and treatment of VTE is managed with anticoagulant therapy, historically parenteral anticoagulants such as unfractionated heparin, low molecular weight heparin, and fondaparinux, and oral vitamin K antagonist...
Autores principales: | Mandernach, Molly W, Beyth, Rebecca J, Rajasekhar, Anita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556259/ https://www.ncbi.nlm.nih.gov/pubmed/26345156 http://dx.doi.org/10.2147/TCRM.S68010 |
Ejemplares similares
-
Idiopathic pulmonary vein thrombosis treated with apixaban
por: Ngo, Dallis, et al.
Publicado: (2021) -
Apixaban Reduces Hospitalizations in Patients With Venous Thromboembolism: An Analysis of the Apixaban for the Initial Management of Pulmonary Embolism and Deep‐Vein Thrombosis as First‐Line Therapy (AMPLIFY) Trial
por: Liu, Xianchen, et al.
Publicado: (2015) -
Guidance for the treatment of deep vein thrombosis and pulmonary embolism
por: Streiff, Michael B., et al.
Publicado: (2016) -
Erratum to: Guidance for the treatment of deep vein thrombosis and pulmonary embolism
por: Streiff, Michael B., et al.
Publicado: (2016) -
Critical appraisal of dabigatran in the treatment of deep vein thrombosis and pulmonary embolism
por: Ogbonna, Kelechi C, et al.
Publicado: (2015)